Intravenous chlormethiazole- haemolysis with concentrated solutions

Area of Science:

• Pharmacology
• Toxicology
• Veterinary Medicine

Background:

• Current clinical chlormethiazole solutions (0.8%) may necessitate large fluid volumes for infusion.
• Investigating higher concentrations could reduce fluid load but poses potential risks.

Purpose of the Study:

• To evaluate the effects of escalating chlormethiazole concentrations on haemolysis in vivo.
• To determine the threshold concentration of chlormethiazole that induces haemolysis.

Main Methods:

• Infusion of increasing chlormethiazole concentrations (0.8% to 20%) into the inferior vena cavae of anesthetized greyhounds.
• Monitoring of free plasma hemoglobin and blood chlormethiazole levels at regular intervals.
• Control group received 0.8% chlormethiazole with hyperosmolar dextrose solutions.

Main Results:

• Rapid progressive haemolysis was observed with 5% and 10% chlormethiazole solutions.
• No haemolysis occurred in control animals receiving the 0.8% solution.
• Chlormethiazole blood levels remained consistent across groups; infusion tubing absorption was minimal at higher concentrations.

Conclusions:

• Chlormethiazole concentrations exceeding 5% to 10% are associated with rapid haemolysis when infused into the inferior vena cava.
• Higher chlormethiazole concentrations may pose a haemolytic risk, necessitating careful dose selection in clinical practice.